Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993246priorityCriticalpatent/ECSP993246A/en
Publication of ECSP993246ApublicationCriticalpatent/ECSP993246A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se proporcionan composiciones farmacéuticas que comprenden uno o más unidades de dosis o formas farmacéuticas administrables por via oral, cada una de las cuales comprende celecoxib particulado en una cantidad de aproximadamente 10 a aproximadamente 1000mg en mezcla íntima con uno o más excipientes farmacéuticamente aceptables. Las composiciones y trastornos mediados por la ciclooxigenasa-2.Pharmaceutical compositions comprising one or more orally administrable dosage units or dosage forms are provided, each comprising particulate celecoxib in an amount of from about 10 to about 1000mg in intimate admixture with one or more pharmaceutically acceptable excipients. Compositions and disorders mediated by cyclooxygenase-2.
USE OF A PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO BE USED IN THE TREATMENT OF DISEASES OF PULMONARCHRONIC OBSTRUCTION AND OF A KIT INCLUDING FORMOTEROL OR A SALT OR SOLVATE OF THE SAME AND BUDESONIDE
COMPOSITION OF VALDECOXIB INTRAORAL DISINTEGRATION, PROCESS FOR PREPARATION, TABLET OBTAINED AND THE USE OF SUCH COMPOSITION IN THE PREPARATION OF A MEDICINAL PRODUCT.